Compare FDA's record on Vioxx with its record on RU-486. Two women died from secondary infections after using RU-486 to terminate their pregnancies, and FDA immediately moved to heighten its warnings. But it took 27,000 people dying from heart attack and strokes while taking Merck's Vioxx before that drug was pulled. Is the FDA just more eager to play abortion politics than to save the elderly and arthritis patients? Stephen Pizzo poses these provocative -- and hitherto unasked -- questions in this TomPaine column.